www.fdanews.com/articles/158748-u-s-fda-accepts-epanova-nda
U.S. FDA Accepts Epanova NDA
September 18, 2013
The FDA has accepted AstraZeneca’s NDA for Epanova, a drug that treats patients with extremely high triglyceride levels.
The Pharma Letter
The Pharma Letter